Имуномодулиращо и противовъзпалително действие на чесън - английски език

Източник - https://www.hindawi.com/journals/jir/2015/401630/

Impact Factor 3.276 

Journal of Immunology Research
Volume 2015 (2015), Article ID 401630, 13 pages
http://dx.doi.org/10.1155/2015/401630

Review Article

Immunomodulation and Anti-Inflammatory Effects of Garlic Compounds

Rodrigo Arreola,1 Saray Quintero-Fabián,2 Rocío Ivette López-Roa,3 Enrique Octavio Flores-Gutiérrez,4 Juan Pablo Reyes-Grajeda,5 Lucrecia Carrera-Quintanar,6 and Daniel Ortuño-Sahagún6

1Psychiatric Genetics Department, National Institute of Psychiatry, “Ramón de la Fuente”, Clinical Research Branch, Calzada México-Xochimilco 101, Colonia San Lorenzo Huipulco, Tlalpan, 14370 Mexico City, DF, Mexico
2Unidad de Genética de la Nutrición, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Instituto Nacional de Pediatría, Avendia del Iman No. 1, Cuarto Piso, 04530 Mexico, DF, Mexico
3Departamento de Farmacobiología, CUCEI, Universidad de Guadalajara, Boulevard Marcelino García Barragán, No. 1421, Esq. Calzada Olímpica, 44430 Guadalajara, JAL, Mexico
4National Institute of Psychiatry, “Ramón de la Fuente”, Clinical Research Branch, Calzada México-Xochimilco 101, Colonia San Lorenzo Huipulco, Tlalpan, 14370 Mexico City, DF, Mexico
5Instituto Nacional de Medicina Genómica, Periférico Sur No. 4809, Colonia Arenal Tepepan, Delegación Tlalpan, 14610 México, DF, Mexico
6Instituto de Investigación en Ciencias Biomédicas (IICB), CUCS, Universidad de Guadalajara, Sierra Mojada No. 950, Colonia Independencia, 44340 Guadalajara, JAL, Mexico

Received 20 October 2014; Revised 24 January 2015; Accepted 25 January 2015

Academic Editor: Oscar Bottasso

Copyright © 2015 Rodrigo Arreola et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

The benefits of garlic to health have been proclaimed for centuries; however, only recently have Allium sativum and its derivatives been proposed as promising candidates for maintaining the homeostasis of the immune system. The complex biochemistry of garlic makes it possible for variations in processing to yield different preparations with differences in final composition and compound proportion. In this review, we assess the most recent experimental results, which indicate that garlic appears to enhance the functioning of the immune system by stimulating certain cell types, such as macrophages, lymphocytes, natural killer (NK) cells, dendritic cells, and eosinophils, by mechanisms including modulation of cytokine secretion, immunoglobulin production, phagocytosis, and macrophage activation. Finally, because immune dysfunction plays an important role in the development and progress of several diseases, we critically examined immunoregulation by garlic extracts and compounds isolated, which can contribute to the treatment and prevention of pathologies such as obesity, metabolic syndrome, cardiovascular disorders, gastric ulcer, and even cancer. We concluded that A. sativum modulates cytokine secretion and that such modulation may provide a mechanism of action for many of their therapeutic effects.

1. Introduction

Plants of the genus Allium are known for their production of organosulfur compounds, which possess interesting biological and pharmacological properties. Among these, garlic (Allium sativum) is one of the most widely used ones. When extracted and isolated, these compounds exhibit a broad spectrum of beneficial effects against microbial infections as well as cardioprotective, anticancerigenic, and anti-inflammatory activity [1–5].

Preparations of garlic are mainly liquid (aqueous, oil, or solvent extracts) or solid (dried garlic powder and fresh cataplasm). These extractions can be based on water formulations, oils, or by using solvents as alcohols [6]. Composition of the extracts depends on the source of the garlic strain, age, storage conditions, and type of processing, and the effects of the extracts are influenced by the method of consumption [7]. Biological effects of different garlic preparations and extracts are summarized in Table 1.

Table 1: Biological effects of different types of garlic preparations and extracts.

The wide variety of effects that has been reported of garlic preparations and extracts with beneficial and useful properties may be due to their numerous compounds (organosulfur and others) contained in different concentrations, which is being a challenge to separate and identify compounds with potential beneficial properties on the human immune and cardiovascular systems [7]. A comprehensive classification of the different compound derived from garlic, as well as their biological effects reported, is actually in preparation and will be published elsewhere (Rodrigo-Arreola et al., in preparation). The presence and potency of garlic compounds vary with respect to mode of garlic preparation and extraction. Additionally, the proportion of these compounds is poorly controlled with the methods used to generate different garlic preparations, the main problem being reproducibility and validation of the real effects observed.

2. Main Organosulfur Compounds Purified from Garlic Preparations

The presence of garlic compounds varies with respect to mode of garlic preparation and extraction as follows: (1) fresh bulbs main compounds are S-allyl-L-cysteine sulfoxide (alliin) and γ-glutamyl cysteine derivatives; (2) in steam distilled oils, sulfide family compounds are the main compounds; (3) powder from crushed and dried garlic contains alliin and diallyl disulfide (DADS); (4) macerates (ground garlic) are enriched extractions with sulfide family compounds, dithiines, and (E–Z)-ajoene compounds, and (5) AGE (soaked, sliced, aged garlic extract in ethanol solution) contains S-allyl-L-cysteine (SAC) and S-allyl mercaptocysteine (SAMC) [40].

Garlic compounds can be divided in several groups or families of compounds. Among these families, we findγ-glutamyl cysteine derivatives, the primary precursor components of the alliin and allyl methyl cysteine (methiin) compound families [6, 41], that produce, by enzymatic action of alliinase (alliin lyase, EC: 4.4.1.4), the diallyl thiosulfinate (Allicin) and allyl methyl thiosulfinate (AM) compound families [41, 42], which are precursors of several organosulfur compound families (i.e., the ajoene and dithiin families) [8]. Additionally, garlic preparations contain nonorgan sulfured compounds, such as tetrahydro-beta-carbolines [43, 44], fructans, and glucose-linked β-D-fructofuranosyl [45], identified in AGE preparations [25].

3. Immunomodulatory Properties of Allium sativum

Immunomodulation is one of the main targets for synthetic drugs and chemicals. However, its high cost, anticipated toxicity, and adverse event effects render it undesirable for the patients. In contrast, the use of herbal plants as health promoters is gaining increasing attention in both consumers and scientific circles. In the literature, several plants have been listed that exhibit immunomodulatory actions, like modulation of cytokine secretion; phagocytosis promotion and macrophage activation; immunoglobulin production; allergic reactions and lymphocyte proliferation [46]. Recently, garlic has been suggested as a promising candidate for maintaining the homeostasis of the immune system. Several studies have been carried out in animal models to examine the effect of different garlic components and formulations on immunomodulatory activities (summarized in Table 2).

Table 2: Immunoregulatory properties of garlic.

3.1. Modulation of Cytokine Secretion by Garlic Derivatives

Herbal medicines with immunomodulatory activity alter the immune function through the dynamic regulation of molecules such as cytokines and chemokines. Altering cytokine expression and targeting their receptors may offer therapeutic potential. Current pharmacological strategies include cytokine antagonist, agonist, inhibition, and stimulation models. However, in light of the adverse events experienced with cytokine-targeted therapy, it could be useful to consider the use of phytotherapy in the modulation of cytokine expression [47]. Recently, Quintero-Fabián et al. examined the effects of alliin in lipopolysaccharide- (LPS-) stimulated 3T3-L1 adipocytes. Incubation of cells for 24 h with 100 μmol/L alliin prior to LPS (100 ng/mL) stimulation for 1 h prevented an increase in the expression of proinflammatory genes IL-6, MCP-1, and Egr-1 and in the protein levels of IL-6 and MCP-1. Interestingly, the phosphorylation of ERK1/2, which is involved in LPS-induced inflammation in adipocytes, decreased following alliin treatment. Furthermore, gene expression profile by microarray evidences an upregulation of genes involved in immune response and downregulation of genes related with cancer [30]. Indeed SAC, caffeic acid (CA), uracil, diallyl trisulfide (DATS, as known as Allitridin), diallyl sulfide (DAS), and other garlic-derived compounds can inhibit transcription factor NF-κB, a master regulator, inhibiting the transcription of several cytokine genes involved in proinflammatory responses, such as TNF-α, interleukin-1beta (IL-1β), IL-6, MCP-1, and IL-12(p70) [25,48–50].

3.2. Phagocytosis Promotion and Macrophage Activation

The Th1 cytokine pattern is essential for controlling parasite load during the early phase of malaria infection. Feng et al. found that allicin administered to Balb/c mice postinfected with Plasmodium yoelii reduced parasitemia and prolonged survival due to the enhancement of proinflammatory mediators such as interferon-gamma (IFN-γ); additionally, allicin treatment stimulated the expansion of CD4+ T cells and macrophages [34]. The antimicrobial activity of allicin was demonstrated by modulation of the cytokines activating macrophages that controlled the parasitic infection.

3.3. Immunoglobulin Production

Modulation by means of a Th2 profile aids in the generation of an efficient humoral immune response. Washiya et al. investigated, in a mouse model, the effects of an oil-macerated garlic extract that contained Z-ajoene. The authors found that fecal IgA levels increased after 3 weeks of treatment and concluded that ajoene may have exerted an influence on B-cell stimulation or interleukin secretion [36]. Hanieh et al. proved that dietary Allium sativum and Allium cepa at low doses in white Leghorn chickens, following immunization with Newcastle Disease Virus (NDV), Sheep red blood cells (SRBC), and Brucella abortus (BA), enhanced anti-NDV, anti-SRBC, and anti-BA antibody production. The authors concluded that enhanced T cell proliferation with dietary garlic might has directly/indirectly enhanced B-cell proliferation and differentiation [35]. However, opposite results have been reported with garlic in the induction of antibody secretion. Jafari et al. reported that supplementing broilers with garlic do not have any beneficial effects on antibody production [51]. Therefore, more studies with garlic and its derivatives are necessary in order to clarify the mechanism implicated in immunoglobulin production.

3.4. Antiallergic and Allergic Properties of Garlic

An allergic reaction involves the secretion of immunoglobin E (IgE) and inflammatory mediators by immune cells. Kyo et al. found that AGE possesses antiallergic properties. In a rat basophil cell line, RBL-2H3, these authors induced histamine release with monoclonal antibodies, and after AGE administration, this significantly inhibited the antigen-specific histamine release. In addition, in a mouse model, orally administered (o.a.) AGE significantly decreased the index of immunoglobulin IgE-mediated skin reaction [37]. Zare et al. investigated the effect of intraperitoneal (i.p.) injections of AGE on an established allergic-airway inflammation murine model and observed that AGE treatment caused a significant decrease in the hallmark criteria of allergic-airway inflammation [38]. On the other hand, dietary garlic lectins have been shown to release histamine from mast cells and basophils as a result of their interaction with cell-surface IgE molecules [52]. Recently, Clement et al. isolated three immunomodulatory proteins (QR-1, QR-2, and QR-3) from raw garlic. In humans, skin prick test (SPT) using QR-1 and QR-2 on atopic and nonatopic subjects revealed that ~26% (in the case of QR-2) of atopic subjects demonstrated a positive reaction, compared with negative reactions in the case of nonatopic (normal) subjects. QR-2 induced histamine release from leukocytes to a much greater degree in the case of atopics compared with nonatopics [39]. Results noted the propensity of garlic lectins to nonspecifically activate mast cells and basophils in atopics as a result of the higher density of IgE in these patients.

3.5. Immunostimulatory Activities of Garlic

Fructooligosaccharides (FOS) are fructans that are naturally present in garlic. Chandrashekar et al. isolated fructans present in AGE: high molecular weight (>3.5 kDa; HF) and low molecular weight (<3 kDa; LF), which were assessed in an immunostimulatory mouse model. Both HF and LF displayed mitogenic activity and activation of macrophages including phagocytosis. These activities were comparable with those of known polysaccharide immunomodulators, such as zymosan and mannan [45]. Additionally, similar results have been obtained with immunoproteins QR-1, QR-2, and QR-3, present in garlic and identified as lectins or agglutinins [39] were previously described as ASA II and ASA I [53], and their mitogenic and comitogenic properties were confirmed as comparable with potent mitogenic lectins ConA and PHA. On the other hand, it is well known that fructans selectively stimulate some beneficial bacteria in colon, modulating different immune responses [54, 55].

Despite increasing evidence, the different components in garlic responsible for effective immune stimulation or inhibition are not known conclusively, and it is likely that several components are responsible for its immunopharmacological mechanisms. Therefore, further research on garlic fructans may cast light on the underlying mechanisms of immunomodulation and should aid in identifying potential uses of garlic fructans in various therapeutic applications [45].

4. Effects of Garlic Compounds/Extracts on Cells of the Immune System

Different studies have shown that garlic compounds are able to perform antiapoptotic [56], antiparasitic [11], proapoptotic, anticancerigenic [57], and immunomodulatory [58, 59] effects on different cells.

It was observed in a murine macrophages cell line infected with Leishmania that AGE induced IL-12 production [11] and, in addition, INF-γ and inducible nitric oxide synthase (iNOS) were overexpressed [12]. However, in peripheral blood monocytes, AGE upregulated IL-10 and decreased IL-12 production [60], which might cause downregulation of proinflammatory cytokines TNF-α, IL-6, INF-γ, and IL-2 by T cells and it acts as negative feedback in the signaling proinflammatory response [60–62]. Additionally, DADS decrease NO production, proinflammatory cytokines, and protein expression in a mouse leukaemic monocyte/macrophage cell line [63]. Therefore, garlic compounds could act as immunomodulatory agents on the macrophages response.

Other studies conducted in mice have been shown that DATS can enhance the antiviral immune response to murine cytomegalovirus (MCMV) [64], by blocking Treg in vivo in chronic MCMV infection [65]. Additionally, the protein fraction of fresh garlic stimulates the peripheral blood T-lymphocyte proliferation and increases CD8+ subpopulation in treated animals, causing an increase in delayed-type hypersensitivity responses, promoting an efficient cellular response [66]. However, these studies did not assess the cytokine profile, which could provide more information about the immunomodulatory role of different garlic protein subfractions.

It has been documented that garlic or its compounds induce a variety of immunomodulatory activities in leukocyte cytokine production. In Th1 cells, inflammatory cytokine production is reduced significantly in the presence of garlic extract and/or its compounds, revealing a potential therapeutic use in inflammatory conditions such as inflammatory bowel disease (IBD) [60] and malaria [34]. However, it is also known that garlic oil shifts the Th1-Th2 balance toward the Th2 type [21].

Furthermore, garlic derivatives exert both stimulatory [1] and inhibitory effects on whole blood cultures of monocytes and lymphocyte proliferation and LPS-induced TNF-α generation through IL-10 production, which controls proinflammatory cytokines [60]. Moreover, other compounds, such as allicin, exert negative effects on human T-cell migration through fibronectin by downregulating actin reorganization [67]. Even more so, protein fraction 4, isolated from AGE, enhances the cytotoxic activity of human peripheral blood lymphocytes (HPBL) in synergy with IL-2 and independently from INF-γ or TNF-α [68].

Finally, the γδ-T population, as a unique type of T cell that recognizes and responds to pathogen-associated molecular patterns (PAMP), increases its proliferation by AGE supplementation in healthy humans [69]. Taken together, these data strongly suggest that garlic compounds and its derivatives are involved in the cellular immune response, acting as immunoregulators; however, more studies are needed to clarify its use in immunotherapy.

Proteins isolated from garlic modulate NK cell line activity in the mesenteric lymph node of mouse [70], while AGE modulates the number and the activity of NK cells in patients with various advanced cancers [71] and also increases NK activities against different cancerous cell lines [72]. Moreover, in healthy subjects, AGE increases the NK cell population [69]. Therefore, garlic acts as a proliferation inductor for this cell type.

Mature dendritic cells (DC) can activate naïve lymphocytes and play a critical role in the induction of primary immune response [73]. Allicin treatment could promote the maturation of DC by increasing the expression of costimulatory molecules such as CD40, yielding an enhancement of the proinflammatory immune response in a rodent malaria model [34]. However, it was not possible to establish whether the 14 kDa protein isolated from AGE induced mouse DC in vitro maturation by an increase in the expression of the CD40 molecule in DC [74]. Consequently, future studies are needed to determine the effect of garlic on DC.

Garlic allergens have been reported as causing hypersensitivity reactions in both patients and animal models [75–77], such as dermatitis [78], rhinoconjunctivitis, asthma [79–81], urticaria [82], and anaphylaxis [83] after ingestion of garlic. This can be due to cross-reactivity in patients with oral allergy [82]. Recently, it was demonstrated that a 56-kDa protein of alliin lyase is the major IgE-binding protein in patients allergic to garlic. Alliin lyase contains a carbohydrate with free terminal α-D-glucopyranoside or α-mannopyranoside residues, thought to bind human IgE in subjects with allergy and to lead to cross-reactivity [77]. Additionally, three protein components from raw garlic displayed hemagglutination and mannose-binding activities; one of these induces histamine release from human leukocytes [39]; likewise, garlic lectins are able to evoke immunogenicity [39, 84]. However, the molecular basis of the interaction between food allergens and the immune system is not clear.

5. Role of Garlic Compounds in Inflammatory Disorders

Numerous research works have shown the immunomodulatory and immunotherapeutic potentials of AGE as a whole, including free radical-mediated anti-inflammatory, anticancer, and antiangiogenic effects, as well as improving hyperglycemia and dyslipidemia, cardiovascular diseases, infectious diseases, autoimmune diseases, and allergy, which have been shown in both animal models and cell lines [28, 85–87]. It is known that the aqueous garlic extract exerts antioxidant action by scavenging reactive oxygen species (ROS) and enhancing cellular antioxidant enzymes such as superoxide dismutase, catalase, and glutathione peroxidase. In addition, garlic represents an important source of antioxidants due to phytochemicals such as DAS and SAMC [28, 88].

5.1. Metabolic Syndrome

The metabolic syndrome is a cluster of abnormalities including hypertension, insulin resistance, hyperlipidemia, glucose intolerance, and abdominal obesity. This syndrome frequently precedes type 2 diabetes and atherosclerosis [89]. The role of garlic has been studied in some of these pathologies, and their effects on the immune system components associated with the proinflammatory state of metabolic syndrome include modulation of oxidative stress (OS), proapoptotic signal pathways, inflammatory mediators, and cellular activities.

5.1.1. Cardiovascular Disorders

Cardiovascular diseases (CVD) continue to accelerate globally and remain the largest cause of deaths worldwide. CVD include diseases of the heart, vascular diseases of the brain, and diseases of blood vessels [90]. Plasma markers of inflammation have also been evaluated as potential tools for prediction of the risk of coronary events. Among these are markers of systemic inflammation, such as high-sensitivity C-reactive protein (CRP), and acute-phase protein [91], serum amyloid A, cytokines such as IL-6, and adhesion molecules such as soluble intercellular adhesion molecule type 1 (ICAM-1) [92, 93] and vascular cell adhesion molecule-1 (VCAM-1) [94]. The participation of ROS and the activity of endothelial nitric oxide synthase (eNOS) in vascular alterations [95, 96] have been reported.

Several studies in vitro, have confirmed the cardioprotective effects of garlic on primary cultured cardiac myocytes, fibroblasts, and endothelial cells, by reducing the production of ROS and blocking ROS-dependent extracellular signal-regulated kinase (ERK)1/2, JNK1/2, AKT, NF-κB, and SMADS signaling [25, 97, 98]. However, garlic powder exerts no detectable effects on CRP, TNF-α, ICAM-1, lipid concentrations, and risk markers for inflammatory processes associated with subjects with atherosclerosis and CVD [99]; additionally, AGE does not change plasma cholesterol level or ICAM-1 expression in a rabbit model of atherosclerosis [100]. However, studies do not reflect the entire population-at-risk for atherosclerosis and cardiovascular diseases because these studies underwent adverse events in disease course (e.g., significant numbers of subjects withdrew from the study). In contrast, recent data showed that long-term administration of aqueous garlic was capable of attenuating VCAM-1 expression in fructose-fed rats. Therefore, garlic compounds reduce vascular inflammation [25, 94].

Atherosclerosis is recognized as a complex disease characterized by an excessive inflammatory, fibrofatty, and proliferative response to damage in the vascular endothelium and involving several cell types, particularly smooth muscle cells, monocyte-derived macrophages, T-lymphocytes, and platelets [101, 102]. Clinical reports have revealed the potential benefits of garlic as a modulator of multiple cardiovascular features through lowering low-density lipoproteins (LDL) and blood pressure [103–106], reducing platelet aggregation and adhesion, preventing LDL oxidation, and reducing the progression of atherosclerosis [100,107–109]. However, it is known that some garlic compounds, such as DADS and allyl mercaptan, did not inhibit the transcriptional activity of factor NF-κB employing human umbilical endothelial cells, suggesting that they play a pivotal role in atherogenesis by regulating the expression of proinflammatory genes and of NF-κB-regulated genes, suggesting that NF-κB is not the major target of DADS and allyl mercaptan. Accordingly, there are differential effects among different organosulfur compounds of garlic [110]; thus, more research is needed to discriminate the beneficial effects accurately and to ascribe these to specific garlic compounds.

5.1.2. Obesity

Obesity is associated with low-grade chronic inflammation characterized by abnormal cytokine production, increased acute-phase reactants, and other mediators in response to excess nutrients in metabolic cells [111]. Activation of a network of inflammatory signaling pathways in the cell eventually causes the activation of specialized immune cells and leads to an unresolved inflammatory response within the tissue [112]. Thus, macrophage [113], mast-cell [114], and NK-cell [115] infiltration is present in obese adipose tissue, which participates in the inflammatory changes in obesity and contributes to insulin resistance [113].

Garlic 1,2-vinyldithiin reduces the secretion of IL-6 and MCP-1, -2 in human preadipocytes treated with macrophage factors. Both molecules are associated with inflammation and the metabolic complications of obesity [116]. Recently, our group demonstrated that alliin prevents the increase of genes and proteins related with the proinflammatory state induced by LPS in 3T3-L1 adipocytes, through the toll-like receptor-4 (TLR-4) pathway and possibly, by regulating ERK1/2 activity [30].

5.1.3. Ulcerogastric Pathologies

In gastric pathophysiology, T and B cells are clearly involved. OS causes damage to lipids, proteins, and DNA [28, 117]. In this respect, garlic has been studied as a gastroprotective agent. AGE capsules have been capable of resolving indomethacin-induced OS in gastric tissue through a reduction of TNF-α and malondialdehyde levels and reduction of myeloperoxidase activity, as well as increasing total glutathione, superoxide dismutase, and catalase activities in animal model [28]. Additionally, garlic oil administered to rats prior to ethanol administration induced a decrease in ulcer index and lipid peroxidation and ameliorated the decrease in antioxidant enzyme levels caused by ethanol [118]. Therefore, garlic can be considered an excellent preventive and protective agent to reduce gastric pathologies.

The anti-inflammatory effect of the garlic extract by IL-10 deregulation and the reduction of IL-12 production in Inflammatory bowel disease (IBD) prevents IL-12 from binding to its receptor on T and NK cells, causing inhibition of the production of IFN-γ [60].

5.1.4. Cancer

Numerous health benefits have been ascribed to organosulfur compounds, including its immunomodulatory properties in cancer [9, 119–121]. A report in the literature noted an association between garlic consumption and decreased incidence of distal colon cancer in women in a cohort study [120]. It has been proposed that allicin presents antitumor activity in situ [122]. More specifically, cultured Ehrlich ascites carcinoma (EAC) cells treated with tamoxifen and supplemented with allicin resulted in cytotoxic damage markers and a decrease in TNF-α levels [121]. Hence, a beneficial role of allicin is suggested as an adjuvant to tamoxifen treatment in cancer.

Recent work also showed that SAC and DATS cause inhibition of PI3K/Akt, JNK apoptotic pathways in human ovarian, and T24 human bladder cancer cells [57, 123]. Even more allicin induces apoptosis through JNK pathway activation and mitochondrial Bax translocation in cells human ovarian cell line SKOV3 [124]. Other studies have demonstrated the role of protein fractions from garlic bulbs in tumor growth and intratumor-infiltrated T lymphocytes in mice transplanted with mammary tumor cells [66], as well as a significant decrease in the size of mouse mammary tumor [70] and complete suppression of growth of Human erythroleukemia cell line HEL in a dose-dependent manner [125]. Recently, our group evidenced that alliin treatment of 3T3-cell-derived adipocytes is capable of downregulating several cancer-related genes [30]. Thus, garlic compounds could significantly affect the tumor development, thorough, at least, their antiproliferative action.

Other groups have shown that fraction 4 of AGE, combined with IL-2 administration, could be employed in tumor immunotherapy, because these increase the cytotoxicity of T-cell lineage [68], and it has been proposed that the sulfhydryl-group hydrophobic portion of proteins, as well as estrogen receptors with cysteine residues in hormone-binding, could be target of inhibition from organosulfur compounds of garlic, (e.g., allyl sulfides). This may be of greater benefit in the prevention of hormone-responsive carcinogenesis [125]. Thus, while total sulfur may be comparable, marked differences in specific organosulfur components likely exist among the preparations studied [126], which strongly suggest that the antitumor effect of allyl sulfur compounds may be related with both their anti-inflammatory and their immunostimulatory properties.

6. Concluding Remarks

Garlic is one of the most employed seasonings for cooking. In addition to its use as a food additive, garlic has been long used in traditional medicine with protective and curative purposes. At present, the trend toward the use of natural remedies with fewer side effects has given rise to garlic consumption as an alternative therapy for diseases such as cardiovascular diseases, cancer, and microbial infections. Different dietary garlic formulations, such as powder (tablets), garlic oil (capsules), and aged garlic extracts (tablets, capsules, and liquids), have been incorporated into the globally increased market of garlic bioactive compounds. However, the variety of manufacturing processes of garlic comprises important issues when choosing a garlic supplement, due to that these processes can markedly influence the composition of the garlic product and thus its biological effects.

Garlic as an herbal medicine or its different bioactive molecules and formulations have been extensively probed in in vitro/in vivo animal models to examine its anti-inflammatory and immunomodulatory properties. One of the main mechanisms observed is through modulation of cytokine profiles and, on the other hand, direct stimulation of immune cells. Although there is sufficient scientific evidence on the beneficial effects of garlic as therapy under different pathological conditions in animal models, human clinical studies are scarce and methodologically weak, with short duration and a reduced number of patients. Therefore, it is mandatory to establish general criteria to finally probe the variety of nutritional and health-promoting properties of garlic.

Conflict of Interests

The authors declare that there is no conflict of interests regarding the publication of this paper.

Authors’ Contribution

Rodrigo Arreola, Saray Quintero-Fabián, Rocío Ivette López-Roa, Enrique Octavio Flores-Gutiérrez, Juan Pablo Reyes-Grajeda, Lucrecia Carrera-Quintanar, and Daniel Ortuño-Sahagún drafted the paper. All authors reviewed the paper and approved the final version. Rodrigo Arreola, Saray Quintero-Fabián, and Rocío Ivette López-Roa had equal contributions.

Acknowledgments

This work was partially supported by grants from CONACYT-Postdoctoral 295457 to Saray Quintero-Fabián and CONACYT-Postdoctoral 170901 to Lucrecia Carrera-Quintanar and also by grant from Universidad de Guadalajara 222769-PROSNI-2014 to Daniel Ortuño-Sahagún. Apologies are due to authors whose works have not been reviewed and to those whose papers have not received the emphasis that they merit. The authors also apologize to authors whose work has not been appropriately cited due to space limitations and/or to limitations of the present paper’s authors’ knowledge.

References

1. H. Salman, M. Bergman, H. Bessler, I. Punsky, and M. Djaldetti, “Effect of a garlic derivative (alliin) on peripheral blood cell immune responses,” International Journal of Immunopharmacology, vol. 21, no. 9, pp. 589–597, 1999. View at Publisher · View at Google Scholar · View at Scopus
2. K. M. Reinhart, R. Talati, C. M. White, and C. I. Coleman, “The impact of garlic on lipid parameters: a systematic review and meta-analysis,” Nutrition Research Reviews, vol. 22, no. 1, pp. 39–48, 2009. View at Publisher · View at Google Scholar · View at Scopus
3. S. Eilat-Adar, T. Sinai, C. Yosefy, and Y. Henkin, “Nutritional recommendations for cardiovascular disease prevention,” Nutrients, vol. 5, no. 9, pp. 3646–3683, 2013. View at Publisher · View at Google Scholar · View at Scopus
4. T. N. Khatua, R. Adela, and S. K. Banerjee, “Garlic and cardioprotection: insights into the molecular mechanisms,” Canadian Journal of Physiology and Pharmacology, vol. 91, no. 6, pp. 448–458, 2013.View at Publisher · View at Google Scholar · View at Scopus
5. S. Fridman, T. Sinai, and D. Zilberg, “Efficacy of garlic based treatments against monogenean parasites infecting the guppy (Poecilia reticulata (Peters)),” Veterinary Parasitology, vol. 203, no. 1-2, pp. 51–58, 2014. View at Publisher · View at Google Scholar · View at Scopus
6. H. Amagase, B. L. Petesch, H. Matsuura, S. Kasuga, and Y. Itakura, “Intake of garlic and its bioactive components,” Journal of Nutrition, vol. 131, supplement 3, pp. 955s–962s, 2001. View at Google Scholar· View at Scopus
7. G. P. Sivam, “Protection against Helicobacter pylori and other bacterial infections by garlic,” Journal of Nutrition, vol. 131, no. 3, pp. 1106s–1108s, 2001. View at Google Scholar · View at Scopus
8. L. D. Lawson and C. D. Gardner, “Composition, stability, and bioavailability of garlic products used in a clinical trial,” Journal of Agricultural and Food Chemistry, vol. 53, no. 16, pp. 6254–6261, 2005. View at Publisher · View at Google Scholar · View at Scopus
9. G. P. Sivam, J. W. Lampe, B. Ulness, S. R. Swanzy, and J. D. Potter, “Helicobacter pylori—in vitro susceptibility to garlic (Allium sativum) extract,” Nutrition and Cancer, vol. 27, no. 2, pp. 118–121, 1997. View at Publisher · View at Google Scholar · View at Scopus
10. D. Jonkers, J. Sluimer, and E. Stobberingh, “Effect of garlic on vancomycin-resistant enterococci,”Antimicrobial Agents and Chemotherapy, vol. 43, no. 12, p. 3045, 1999. View at Google Scholar · View at Scopus
11. M. J. Gharavi, M. Nobakht, S. Khademvatan, F. Fani, M. Bakhshayesh, and M. Roozbehani, “The effect of aqueous garlic extract on interleukin-12 and 10 levels in Leishmania major (MRHO/IR/75/ER) infected macrophages,” Iranian Journal of Public Health, vol. 40, no. 4, pp. 105–111, 2011. View at Google Scholar · View at Scopus
12. M. Gharavi, M. Nobakht, S. Khademvatan, E. Bandani, M. Bakhshayesh, and M. Roozbehani, “The effect of garlic extract on expression of INFγ and inos genes in macrophages infected with Leishmania major,” Iranian Journal of Parasitology, vol. 6, no. 3, pp. 74–81, 2011. View at Google Scholar · View at Scopus
13. S. Gorinstein, M. Leontowicz, H. Leontowicz et al., “Supplementation of garlic lowers lipids and increases antioxidant capacity in plasma of rats,” Nutrition Research, vol. 26, no. 7, pp. 362–368, 2006.View at Publisher · View at Google Scholar · View at Scopus
14. A. K. Sharma, A. Munajjam, B. Vaishnav et al., “Involvement of adenosine and standardization of aqueous extract of garlic (Allium sativum Linn.) on cardioprotective and cardiodepressant properties in ischemic preconditioning and myocardial ischemia-reperfusion induced cardiac injury,” Journal of Biomedical Research, vol. 26, no. 1, pp. 24–36, 2012. View at Publisher · View at Google Scholar · View at Scopus
15. I. Durak, M. Kavutcu, B. Aytaç et al., “Effects of garlic extract consumption on blood lipid and oxidant/antioxidant parameters in humans with high blood cholesterol,” Journal of Nutritional Biochemistry, vol. 15, no. 6, pp. 373–377, 2004. View at Publisher · View at Google Scholar · View at Scopus
16. H. Yoshida, H. Katsuzaki, R. Ohta et al., “Antimicrobial activity of the thiosulfinates isolated from oil-macerated garlic extract,” Bioscience, Biotechnology and Biochemistry, vol. 63, no. 3, pp. 591–594, 1999.View at Publisher · View at Google Scholar · View at Scopus
17. L. D. Lawson, S. G. Wood, and B. G. Hughes, “HPLC analysis of allicin and other thiosulfinates in garlic clove homogenates,” Planta Medica, vol. 57, no. 3, pp. 263–270, 1991. View at Publisher · View at Google Scholar · View at Scopus
18. E. A. O'Gara, D. J. Hill, and D. J. Maslin, “Activities of garlic oil, garlic powder, and their diallyl constituents against Helicobacter pylori,” Applied and Environmental Microbiology, vol. 66, no. 5, pp. 2269–2273, 2000. View at Publisher · View at Google Scholar · View at Scopus
19. H. Yoshida, N. Iwata, H. Katsuzaki et al., “Antimicrobial activity of a compound isolated from an oil-macerated garlic extract,” Bioscience, Biotechnology and Biochemistry, vol. 62, no. 5, pp. 1014–1017, 1998. View at Publisher · View at Google Scholar · View at Scopus
20. S. M. Aboelhadid, A. A. Kamel, W. M. Arafa, and K. A. Shokier, “Effect of Allium sativum and Allium cepa oils on different stages of Boophilus annulatus,” Parasitology Research, vol. 112, no. 5, pp. 1883–1890, 2013. View at Publisher · View at Google Scholar · View at Scopus
21. C. T. Liu, H. M. Su, C. K. Lii, and L.- Y. Sheen, “Effect of supplementation with garlic oil on activity of Th1 and Th2 lymphocytes from rats,” Planta Medica, vol. 75, no. 3, pp. 205–210, 2009. View at Publisher · View at Google Scholar · View at Scopus
22. P.-C. Shih, C.-H. Kuo, J.-Y. Juang, C.-H. Liu, L. Hsu, and C.-T. Liu, “Effects of garlic oil on the migration of neutrophil-like cell studied by using a chemotactic gradient labchip,” Journal of Biomedicine and Biotechnology, vol. 2010, Article ID 319059, 9 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
23. E. N. Lee, Y. W. Choi, H. K. Kim et al., “Chloroform extract of aged black garlic attenuates TNF-α-induced ROS generation, VCAM-1 expression, NF-κB activation and adhesiveness for monocytes in human umbilical vein endothelial cells,” Phytotherapy Research, vol. 25, no. 1, pp. 92–100, 2011. View at Publisher · View at Google Scholar · View at Scopus
24. C. Park, S. Park, Y. H. Chung et al., “Induction of apoptosis by a hexane extract of aged black garlic in the human leukemic U937 cells,” Nutrition Research and Practice, vol. 8, no. 2, pp. 132–137, 2014. View at Publisher · View at Google Scholar · View at Scopus
25. S. R. Kim, Y. R. Jung, H. J. An et al., “Anti-wrinkle and anti-inflammatory effects of active garlic components and the inhibition of MMPs via NF-κB signaling,” PLoS ONE, vol. 8, no. 9, Article ID e73877, 2013. View at Publisher · View at Google Scholar · View at Scopus
26. J. Imai, N. Ide, S. Nagae, T. Moriguchi, H. Matsuura, and Y. Itakura, “Antioxidant and radical scavenging effects of aged garlic extract and its constituents,” Planta Medica, vol. 60, no. 5, pp. 417–420, 1994. View at Publisher · View at Google Scholar · View at Scopus
27. C. Borek, “Antioxidant health effects of aged garlic extract,” Journal of Nutrition, vol. 131, no. 3, pp. 1010S–1015S, 2001. View at Google Scholar · View at Scopus
28. G. M. Badr and J. A. Al-Mulhim, “The protective effect of aged garlic extract on nonsteroidal anti-inflammatory drug-induced gastric inflammations in male albino rats,” Evidence-Based Complementary and Alternative Medicine, vol. 2014, Article ID 759642, 9 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
29. N. Uda, N. Kashimoto, I. Sumioka, E. Kyo, S.-I. Sumi, and S. Fukushima, “Aged garlic extract inhibits development of putative preneoplastic lesions in rat hepatocarcinogenesis,” Journal of Nutrition, vol. 136, no. 3, supplement, pp. 855s–860s, 2006. View at Google Scholar · View at Scopus
30. S. Quintero-Fabián, D. Ortuño-Sahagún, M. Vázquez-Carrera, and R. I. López-Roa, “Alliin, a garlic (Allium sativum) compound, prevents LPS-induced inflammation in 3T3-L1 adipocytes,” Mediators of Inflammation, vol. 2013, Article ID 381815, 11 pages, 2013. View at Publisher · View at Google Scholar· View at Scopus
31. A. Makris, C. E. Thornton, B. Xu, and A. Hennessy, “Garlic increases IL-10 and inhibits TNFα and IL-6 production in endotoxin-stimulated human placental explants,” Placenta, vol. 26, no. 10, pp. 828–834, 2005. View at Publisher · View at Google Scholar · View at Scopus
32. H.-P. Keiss, V. M. Dirsch, T. Hartung et al., “Garlic (Allium sativum L.) modulates cytokine expression in lipopolysaccharide-activated human blood thereby inhibiting NF-κB activity,” Journal of Nutrition, vol. 133, no. 7, pp. 2171–2175, 2003. View at Google Scholar · View at Scopus
33. N. S. Kang, E. Y. Moon, C. G. Cho, and S. Pyo, “Immunomodulating effect of garlic component, allicin, on murine peritoneal macrophages,” Nutrition Research, vol. 21, no. 4, pp. 617–626, 2001. View at Publisher · View at Google Scholar · View at Scopus
34. Y. Feng, X. Zhu, Q. Wang et al., “Allicin enhances host pro-inflammatory immune responses and protects against acute murine malaria infection,” Malaria Journal, vol. 11, article 268, 2012. View at Publisher · View at Google Scholar · View at Scopus
35. H. Hanieh, K. Narabara, M. Piao, C. Gerile, A. Abe, and Y. Kondo, “Modulatory effects of two levels of dietary Alliums on immune response and certain immunological variables, following immunization, in White Leghorn chickens,” Animal Science Journal, vol. 81, no. 6, pp. 673–680, 2010. View at Publisher ·View at Google Scholar · View at Scopus
36. Y. Washiya, T. Nishikawa, and T. Fujino, “Enhancement of intestinal IgA production by ajoene in mice,” Bioscience, Biotechnology and Biochemistry, vol. 77, no. 11, pp. 2298–2301, 2013. View at Publisher · View at Google Scholar · View at Scopus
37. E. Kyo, N. Uda, S. Kasuga, and Y. Itakura, “Immunomodulatory effects of aged garlic extract,” Journal of Nutrition, vol. 131, no. 3, pp. 1075s–1079s, 2001. View at Google Scholar · View at Scopus
38. A. Zare, P. Farzaneh, Z. Pourpak et al., “Purified aged garlic extract modulates allergic airway inflammation in Balb/c mice,” Iranian Journal of Allergy, Asthma and Immunology, vol. 7, no. 3, pp. 133–141, 2008. View at Google Scholar · View at Scopus
39. F. Clement, S. N. Pramod, and Y. P. Venkatesh, “Identity of the immunomodulatory proteins from garlic (Allium sativum) with the major garlic lectins or agglutinins,” International Immunopharmacology, vol. 10, no. 3, pp. 316–324, 2010. View at Publisher · View at Google Scholar ·View at Scopus
40. P. Z. Trio, S. You, X. He, J. He, K. Sakao, and D.-X. Hou, “Chemopreventive functions and molecular mechanisms of garlic organosulfur compounds,” Food & Function, vol. 5, no. 5, pp. 833–844, 2014.View at Publisher · View at Google Scholar · View at Scopus
41. M. G. Jones, J. Hughes, A. Tregova, J. Milne, A. B. Tomsett, and H. A. Collin, “Biosynthesis of the flavour precursors of onion and garlic,” Journal of Experimental Botany, vol. 55, no. 404, pp. 1903–1918, 2004. View at Publisher · View at Google Scholar · View at Scopus
42. K. T. Augusti, R. Jose, G. R. Sajitha, and P. Augustine, “A rethinking on the benefits and drawbacks of common antioxidants and a proposal to look for the antioxidants in Allium products as ideal agents: a review,” Indian Journal of Clinical Biochemistry, vol. 27, no. 1, pp. 6–20, 2012. View at Publisher · View at Google Scholar · View at Scopus
43. M. Ichikawa, K. Ryu, J. Yoshida et al., “Antioxidant effects of tetrahydro-beta-carboline derivatives identified in aged garlic extract,” BioFactors, vol. 16, no. 3-4, pp. 57–72, 2002. View at Publisher · View at Google Scholar · View at Scopus
44. M. Ichikawa, J. Yoshida, N. Ide, T. Sasaoka, H. Yamaguchi, and K. Ono, “Tetrahydro-β-carboline derivatives in aged garlic extract show antioxidant properties,” Journal of Nutrition, vol. 136, no. 3, supplement, pp. 726s–731s, 2006. View at Google Scholar · View at Scopus
45. P. M. Chandrashekar, K. V. H. Prashanth, and Y. P. Venkatesh, “Isolation, structural elucidation and immunomodulatory activity of fructans from aged garlic extract,” Phytochemistry, vol. 72, no. 2-3, pp. 255–264, 2011. View at Publisher · View at Google Scholar · View at Scopus
46. Mahima, A. Rahal, R. Deb et al., “Immunomodulatory and therapeutic potentials of herbal, traditional/indigenous and ethnoveterinary medicines,” Pakistan Journal of Biological Sciences, vol. 15, no. 16, pp. 754–774, 2012. View at Publisher · View at Google Scholar · View at Scopus
47. K. Spelman, J. J. Burns, D. Nichols, N. Winters, S. Ottersberg, and M. Tenborg, “Modulation of cytokine expression by traditional medicines: a review of herbal immunomodulators,” Alternative Medicine Review, vol. 11, no. 2, pp. 128–150, 2006. View at Google Scholar · View at Scopus
48. S. You, E. Nakanishi, H. Kuwata et al., “Inhibitory effects and molecular mechanisms of garlic organosulfur compounds on the production of inflammatory mediators,” Molecular Nutrition & Food Research, vol. 57, no. 11, pp. 2049–2060, 2013. View at Publisher · View at Google Scholar · View at Scopus
49. E. Fu, M.-C. Tsai, Y.-T. Chin et al., “The effects of diallyl sulfide upon Porphyromonas gingivalislipopolysaccharide stimulated proinflammatory cytokine expressions and nuclear factor-kappa B activation in human gingival fibroblasts,” Journal of Periodontal Research, 2014. View at Publisher ·View at Google Scholar
50. C. Y. Ho, C. J. Weng, J. J. Jhang, Y. T. Cheng, S. M. Huang, and G. C. Yen, “Diallyl sulfide as a potential dietary agent to reduce TNFalpha- and histamine-induced proinflammatory responses in A7r5 cells,”Molecular Nutrition and Food Research, vol. 58, no. 5, pp. 1069–1078, 2014. View at Publisher · View at Google Scholar · View at Scopus
51. R. A. Jafari, M. R. Jalali, M. Ghorbanpoor, and S. M. R. Saraei, “Effect of dietary garlic on immune response of broiler chicks to live newcastle disease vaccine,” Pakistan Journal of Biological Sciences, vol. 11, no. 14, pp. 1848–1851, 2008. View at Publisher · View at Google Scholar · View at Scopus
52. M. Shibasaki, R. Sumazaki, S. Isoyama, and H. Takita, “Interaction of lectins with human IgE: IgE-binding property and histamine-releasing activity of twelve plant lectins,” International Archives of Allergy and Immunology, vol. 98, no. 1, pp. 18–25, 1992. View at Publisher · View at Google Scholar ·View at Scopus
53. A. Gupta and R. S. Sandhu, “Mitogenic activity of high molecular weight mannose specific agglutinin,”Indian Journal of Biochemistry and Biophysics, vol. 33, no. 4, pp. 325–327, 1996. View at Google Scholar · View at Scopus
54. L. Vogt, D. Meyer, G. Pullens et al., “Immunological properties of inulin-type fructans,” Critical Reviews in Food Science and Nutrition, vol. 55, no. 3, pp. 414–436, 2015. View at Publisher · View at Google Scholar
55. B. Watzl, S. Girrbach, and M. Roller, “Inulin, oligofructose and immunomodulation,” British Journal of Nutrition, vol. 93, pp. S49–S55, 2005. View at Publisher · View at Google Scholar · View at Scopus
56. S. Chen, Y. Tang, Y. Qian et al., “Allicin prevents H2O2-induced apoptosis of HUVECs by inhibiting an oxidative stress pathway,” BMC Complementary and Alternative Medicine, vol. 14, no. 1, article 321, 2014. View at Publisher · View at Google Scholar
57. Y.-S. Xu, J.-G. Feng, D. Zhang et al., “S-allylcysteine, a garlic derivative, suppresses proliferation and induces apoptosis in human ovarian cancer cells in vitro,” Acta Pharmacologica Sinica, vol. 35, no. 2, pp. 267–274, 2014. View at Publisher · View at Google Scholar · View at Scopus
58. D. Bauer, E. Mazzio, K. F. Soliman et al., “Diallyl disulfide inhibits TNFα-induced CCL2 release by MDA-MB-231 cells,” Anticancer Research, vol. 34, no. 6, pp. 2763–2770, 2014. View at Google Scholar
59. S. Y. Park, R. Seetharaman, M. J. Ko et al., “Ethyl linoleate from garlic attenuates lipopolysaccharide-induced pro-inflammatory cytokine production by inducing heme oxygenase-1 in RAW264.7 cells,”International Immunopharmacology, vol. 19, no. 2, pp. 253–261, 2014. View at Publisher · View at Google Scholar · View at Scopus
60. G. Hodge, S. Hodge, and P. Han, “Allium sativum (garlic) suppresses leukocyte inflammatory cytokine production in vitro: potential therapeutic use in the treatment of inflammatory bowel disease,”Cytometry, vol. 48, no. 4, pp. 209–215, 2002. View at Publisher · View at Google Scholar · View at Scopus
61. M. Oft, “IL-10: master switch from tumor-promoting inflammation to antitumor immunity,” Cancer Immunology Research, vol. 2, no. 3, pp. 194–199, 2014. View at Publisher · View at Google Scholar
62. R. T. Gazzinelli, I. P. Oswald, S. L. James, and A. Sher, “IL-10 inhibits parasite killing and nitrogen oxide production by IFN-γ- activated macrophages,” Journal of Immunology, vol. 148, no. 6, pp. 1792–1796, 1992. View at Google Scholar · View at Scopus
63. I. S. Shin, J. Hong, C. M. Jeon et al., “Diallyl-disulfide, an organosulfur compound of garlic, attenuates airway inflammation via activation of the Nrf-2/HO-1 pathway and NF-kappaB suppression,” Food and Chemical Toxicology, vol. 62, pp. 506–513, 2013. View at Publisher · View at Google Scholar · View at Scopus
64. X. Yi, F. Feng, Z. Xiang, and L. Ge, “The effects of allitridin on the expression of transcription factors T-bet and GATA-3 in mice infected by murine cytomegalovirus,” Journal of Medicinal Food, vol. 8, no. 3, pp. 332–336, 2005. View at Publisher · View at Google Scholar · View at Scopus
65. Y.-N. Li, F. Huang, X.-L. Liu et al., “Allium sativum-derived allitridin inhibits treg amplification in cytomegalovirus infection,” Journal of Medical Virology, vol. 85, no. 3, pp. 493–500, 2013. View at Publisher · View at Google Scholar · View at Scopus
66. M. Ebrahimi, Z. M. Hassan, A. Mostafaie, N. Z. Mehrjardi, and T. Ghazanfari, “Purified protein fraction of garlic extract modulates cellular immune response against breast transplanted tumors in BALB/c mice model,” Cell Journal, vol. 15, no. 1, pp. 65–74, 2013. View at Google Scholar · View at Scopus
67. U. Sela, S. Ganor, I. Hecht et al., “Allicin inhibits SDF-1alpha-induced T cell interactions with fibronectin and endothelial cells by down-regulating cytoskeleton rearrangement, Pyk-2 phosphorylation and VLA-4 expression,” Immunology, vol. 111, no. 4, pp. 391–399, 2004. View at Publisher · View at Google Scholar · View at Scopus
68. N. Morioka, L. L. Sze, D. L. Morton, and R. F. Irie, “A protein fraction from aged garlic extract enhances cytotoxicity and proliferation of human lymphocytes mediated by interleukin-2 and concanavalin A,” Cancer Immunology Immunotherapy, vol. 37, no. 5, pp. 316–322, 1993. View at Publisher · View at Google Scholar · View at Scopus
69. M. P. Nantz, C. A. Rowe, C. E. Muller, R. A. Creasy, J. M. Stanilka, and S. S. Percival, “Supplementation with aged garlic extract improves both NK and γδ-T cell function and reduces the severity of cold and flu symptoms: a randomized, double-blind, placebo-controlled nutrition intervention,” Clinical Nutrition, vol. 31, no. 3, pp. 337–344, 2012. View at Publisher · View at Google Scholar · View at Scopus
70. Z. M. Hassan, R. Yaraee, N. Zare, T. Ghazanfari, A. H. S. Nejad, and B. Nozari, “Immunomodulatory affect of R10 fraction of garlic extract on natural killer activity,” International Immunopharmacology, vol. 3, no. 10-11, pp. 1483–1489, 2003. View at Publisher · View at Google Scholar · View at Scopus
71. H. Ishikawa, T. Saeki, T. Otani et al., “Aged garlic extract prevents a decline of NK cell number and activity in patients with advanced cancer,” Journal of Nutrition, vol. 136, no. 3, supplement, pp. 816S–820S, 2006. View at Google Scholar · View at Scopus
72. E. Kyo, N. Uda, A. Suzuki et al., “Immunomodulation and antitumor activities of aged garlic extract,”Phytomedicine, vol. 5, no. 4, pp. 259–267, 1998. View at Publisher · View at Google Scholar · View at Scopus
73. J. Banchereau, F. Briere, C. Caux et al., “Immunobiology of dendritic cells,” Annual Review of Immunology, vol. 18, pp. 767–811, 2000. View at Publisher · View at Google Scholar · View at Scopus
74. H. N. Ahmadabad, Z. M. Hassan, E. Safari, M. Bozorgmehr, T. Ghazanfari, and S. M. Moazzeni, “Evaluation of the immunomodulatory effect of the 14kDa protein isolated from aged garlic extract on dendritic cells,” Cellular Immunology, vol. 269, no. 2, pp. 90–95, 2011. View at Publisher · View at Google Scholar · View at Scopus
75. J. J. Park, J. Lee, M. A. Kim, S. K. Back, S. K. Hong, and H. S. Na, “Induction of total insensitivity to capsaicin and hypersensitivity to garlic extract in human by decreased expression of TRPV1,”Neuroscience Letters, vol. 411, no. 2, pp. 87–91, 2007. View at Publisher · View at Google Scholar ·View at Scopus
76. T. Ghazanfari, Z. M. Hassan, and M. Ebrahimi, “Immunomodulatory activity of a protein isolated from garlic extract on delayed type hypersensitivity,” International Immunopharmacology, vol. 2, no. 11, pp. 1541–1549, 2002. View at Publisher · View at Google Scholar · View at Scopus
77. S. H. Kao, C. H. Hsu, S. N. Su, W. T. Hor, W. H. Chang T, and L. P. Chow, “Identification and immunologic characterization of an allergen, alliin lyase, from garlic (Allium sativum),” Journal of Allergy and Clinical Immunology, vol. 113, no. 1, pp. 161–168, 2004. View at Publisher · View at Google Scholar · View at Scopus
78. E. Cronin, “Dermatitis of the hands in caterers,” Contact Dermatitis, vol. 17, no. 5, pp. 265–269, 1987.View at Publisher · View at Google Scholar · View at Scopus
79. A. E. Falleroni, C. R. Zeiss, and D. Levitz, “Occupational asthma secondary to inhalation of garlic dust,”Journal of Allergy and Clinical Immunology, vol. 68, no. 2, pp. 156–160, 1981. View at Publisher · View at Google Scholar · View at Scopus
80. M. Seuri, A. Taivanen, P. Ruoppi, and H. Tukiainen, “Three cases of occupational asthma and rhinitis caused by garlic,” Clinical and Experimental Allergy, vol. 23, no. 12, pp. 1011–1014, 1993. View at Publisher · View at Google Scholar · View at Scopus
81. J. A. Lybarger, J. S. Gallagher, D. W. Pulver, A. Litwin, S. Brooks, and I. L. Bernstein, “Occupational asthma induced by inhalation and ingestion of garlic,” The Journal of Allergy and Clinical Immunology, vol. 69, no. 5, pp. 448–454, 1982. View at Publisher · View at Google Scholar · View at Scopus
82. R. Asero, G. Mistrello, D. Roncarolo, P. L. Antoniotti, and P. Falagiani, “A case of garlic allergy,” Journal of Allergy and Clinical Immunology, vol. 101, no. 3, pp. 427–428, 1998. View at Publisher · View at Google Scholar · View at Scopus
83. A. J. Pérez-Pimiento, I. Moneo, M. Santaolalla, S. De Paz, B. Fernández-Parra, and A. R. Domínguez-Lázaro, “Anaphylactic reaction to young garlic,” Allergy, vol. 54, no. 6, pp. 626–629, 1999. View at Publisher · View at Google Scholar · View at Scopus
84. F. Clement and Y. P. Venkatesh, “Dietary garlic (Allium sativum) lectins, ASA I and ASA II, are highly stable and immunogenic,” International Immunopharmacology, vol. 10, no. 10, pp. 1161–1169, 2010.View at Publisher · View at Google Scholar · View at Scopus
85. X. Yin, J. Zhang, X. Li et al., “DADS suppresses human esophageal xenograft tumors through RAF/MEK/ERK and mitochondria-dependent pathways,” International Journal of Molecular Sciences, vol. 15, no. 7, pp. 12422–12441, 2014. View at Publisher · View at Google Scholar
86. G. P. Senthilkumar, S. Thomas, K. Sivaraman, P. Sankar, and Z. Bobby, “Study the effect of s-methyl L-cysteine on lipid metabolism in an experimental model of diet induced obesity,” Journal of Clinical and Diagnostic Research, vol. 7, no. 11, pp. 2449–2451, 2013. View at Publisher · View at Google Scholar ·View at Scopus
87. P. M. Chandrashekar and Y. P. Venkatesh, “Identification of the protein components displaying immunomodulatory activity in aged garlic extract,” Journal of Ethnopharmacology, vol. 124, no. 3, pp. 384–390, 2009. View at Publisher · View at Google Scholar · View at Scopus
88. G. Şener, Ö. Sehirli, Y. Ipçi et al., “Aqueous garlic extract alleviates isehaemia-reperfusion-induced oxidative hepatic injury in rats,” Journal of Pharmacy and Pharmacology, vol. 57, no. 1, pp. 145–150, 2005. View at Publisher · View at Google Scholar · View at Scopus
89. P. Ernsberger, J. L. Johnson, T. Rosenthal, D. Mirelman, and R. J. Koletsky, “Therapeutic actions of allylmercaptocaptopril and captopril in a rat model of metabolic syndrome,” American Journal of Hypertension, vol. 20, no. 8, pp. 866–874, 2007. View at Publisher · View at Google Scholar · View at Scopus
90. S. Mendis, P. Puska, and B. Norrving, Global Atlas on Cardiovascular Disease Prevention and Control, World Health Organization, World Heart Federation and World Stroke Organization, 2011.
91. L. H. Kuller, R. P. Tracy, J. Shaten, and E. N. Meilahn, “Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study,” American Journal of Epidemiology, vol. 144, no. 6, pp. 537–547, 1996. View at Publisher · View at Google Scholar · View at Scopus
92. P. M. Ridker, C. H. Hennekens, B. Roitman-Johnson, M. J. Stampfer, and J. Allen, “Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men,” The Lancet, vol. 351, no. 9096, pp. 88–92, 1998. View at Publisher · View at Google Scholar · View at Scopus
93. P. M. Ridker, C. H. Hennekens, J. E. Buring, and N. Rifai, “C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women,” The New England Journal of Medicine, vol. 342, no. 12, pp. 836–843, 2000. View at Publisher · View at Google Scholar · View at Scopus
94. M. A. Vazquez-Prieto, C. Rodriguez Lanzi, C. Lembo, C. R. Galmarini, and R. M. Miatello, “Garlic and onion attenuates vascular inflammation and oxidative stress in fructose-fed rats,” Journal of Nutrition and Metabolism, vol. 2011, Article ID 475216, 7 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
95. T. J. Guzik, J. Sadowski, B. Guzik et al., “Coronary artery superoxide production and nox isoform expression in human coronary artery disease,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 26, no. 2, pp. 333–339, 2006. View at Publisher · View at Google Scholar · View at Scopus
96. R. Miatello, M. Vázquez, N. Renna, M. Cruzado, A. P. Zumino, and N. Risler, “Chronic administration of resveratrol prevents biochemical cardiovascular changes in fructose-fed rats,” The American Journal of Hypertension, vol. 18, no. 6, pp. 864–870, 2005. View at Publisher · View at Google Scholar · View at Scopus
97. C. Liu, F. Cao, Q. Z. Tang et al., “Allicin protects against cardiac hypertrophy and fibrosis via attenuating reactive oxygen species-dependent signaling pathways,” Journal of Nutritional Biochemistry, vol. 21, no. 12, pp. 1238–1250, 2010. View at Publisher · View at Google Scholar · View at Scopus
98. N. Ide and B. H. S. Lau, “Garlic compounds minimize intracellular oxidative stress and inhibit nuclear factor-κB activation,” Journal of Nutrition, vol. 131, no. 3, pp. 1020S–1026S, 2001. View at Google Scholar · View at Scopus
99. M. B. A. van Doorn, S. M. E. Santo, P. Meijer et al., “Effect of garlic powder on C-reactive protein and plasma lipids in overweight and smoking subjects,” The American Journal of Clinical Nutrition, vol. 84, no. 6, pp. 1324–1329, 2006. View at Google Scholar · View at Scopus
100. J. H. Campbell, J. L. Efendy, N. J. Smith, and G. R. Campbell, “Molecular basis by which garlic suppresses atherosclerosis,” Journal of Nutrition, vol. 131, no. 3, 2001. View at Google Scholar · View at Scopus
101. S. Sitia, L. Tomasoni, F. Atzeni et al., “From endothelial dysfunction to atherosclerosis,” Autoimmunity Reviews, vol. 9, no. 12, pp. 830–834, 2010. View at Publisher · View at Google Scholar · View at Scopus
102. N. Morihara, N. Ide, and N. Weiss, “Aged garlic extract inhibits homocysteine-induced scavenger receptor CD36 expression and oxidized low-density lipoprotein cholesterol uptake in human macrophages in vitro,” Journal of Ethnopharmacology, vol. 134, no. 3, pp. 711–716, 2011. View at Publisher · View at Google Scholar · View at Scopus
103. K. Ried, O. R. Frank, and N. P. Stocks, “Aged garlic extract reduces blood pressure in hypertensives: a dose-response trial,” European Journal of Clinical Nutrition, vol. 67, no. 1, pp. 64–70, 2013. View at Publisher · View at Google Scholar · View at Scopus
104. M. Steiner, A. H. Khan, D. Holbert, and R. I.-S. Lin, “A double-blind crossover study in moderately hypercholesterolemic men that compared the effect of aged garlic extract and placebo administration on blood lipids,” The American Journal of Clinical Nutrition, vol. 64, no. 6, pp. 866–870, 1996. View at Google Scholar · View at Scopus
105. K. M. Reinhart, C. I. Coleman, C. Teevan, P. Vachhani, and C. M. White, “Effects of garlic on blood pressure in patients with and without systolic hypertension: a meta-analysis,” Annals of Pharmacotherapy, vol. 42, no. 12, pp. 1766–1771, 2008. View at Publisher · View at Google Scholar ·View at Scopus
106. K. Ried, O. R. Frank, and N. P. Stocks, “Aged garlic extract lowers blood pressure in patients with treated but uncontrolled hypertension: a randomised controlled trial,” Maturitas, vol. 67, no. 2, pp. 144–150, 2010. View at Publisher · View at Google Scholar · View at Scopus
107. M. J. Budoff, N. Ahmadi, K. M. Gul et al., “Aged garlic extract supplemented with B vitamins, folic acid and L-arginine retards the progression of subclinical atherosclerosis: a randomized clinical trial,”Preventive Medicine, vol. 49, no. 2-3, pp. 101–107, 2009. View at Publisher · View at Google Scholar ·View at Scopus
108. A. Gonen, D. Harats, A. Rabinkov et al., “The antiatherogenic effect of allicin: possible mode of action,”Pathobiology, vol. 72, no. 6, pp. 325–334, 2006. View at Publisher · View at Google Scholar · View at Scopus
109. R. C. Jain and D. B. Konar, “Effect of garlic oil in experimental cholesterol atherosclerosis,”Atherosclerosis, vol. 29, no. 2, pp. 125–129, 1978. View at Publisher · View at Google Scholar · View at Scopus
110. V. M. Dirsch, H.-P. Keiss, and A. M. Vollmar, “Garlic metabolites fail to inhibit the activation of the transcription factor NF-kappaB and subsequent expression of the adhesion molecule E-selectin in human endothelial cells,” European Journal of Nutrition, vol. 43, no. 1, pp. 55–59, 2004. View at Publisher · View at Google Scholar · View at Scopus
111. G. S. Hotamisligil, “Inflammation and metabolic disorders,” Nature, vol. 444, no. 7121, pp. 860–867, 2006. View at Publisher · View at Google Scholar · View at Scopus
112. M. F. Gregor and G. S. Hotamisligil, “Inflammatory mechanisms in obesity,” Annual Review of Immunology, vol. 29, pp. 415–445, 2011. View at Publisher · View at Google Scholar · View at Scopus
113. C. N. Lumeng, S. M. Deyoung, J. L. Bodzin, and A. R. Saltiel, “Increased inflammatory properties of adipose tissue macrophages recruited during diet-induced obesity,” Diabetes, vol. 56, no. 1, pp. 16–23, 2007. View at Publisher · View at Google Scholar · View at Scopus
114. J. Liu, A. Divoux, J. Sun et al., “Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice,” Nature Medicine, vol. 15, no. 8, pp. 940–945, 2009.View at Publisher · View at Google Scholar · View at Scopus
115. K. Ohmura, N. Ishimori, Y. Ohmura et al., “Natural killer T cells are involved in adipose tissues inflammation and glucose intolerance in diet-induced obese mice,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 30, no. 2, pp. 193–199, 2010. View at Publisher · View at Google Scholar · View at Scopus
116. M. Keophiphath, F. Priem, I. Jacquemond-Collet, K. Clément, and D. Lacasa, “1,2-vinyldithiin from garlic inhibits differentiation and inflammation of human preadipocytes,” Journal of Nutrition, vol. 139, no. 11, pp. 2055–2060, 2009. View at Publisher · View at Google Scholar · View at Scopus
117. M. M. D'Elios, A. Amedei, and G. Del Prete, “Helicobacter pylori antigen-specific T-cell responses at gastric level in chronic gastritis, peptic ulcer, gastric cancer and low-grade mucosa-associated lymphoid tissue (MALT) lymphoma,” Microbes and Infection, vol. 5, no. 8, pp. 723–730, 2003. View at Publisher ·View at Google Scholar · View at Scopus
118. P. Khosla, R. S. Karan, and V. K. Bhargava, “Effect of garlic oil on ethanol induced gastric ulcers in rats,”Phytotherapy Research, vol. 18, no. 1, pp. 87–91, 2004. View at Publisher · View at Google Scholar ·View at Scopus
119. S. Oommen, R. J. Anto, G. Srinivas, and D. Karunagaran, “Allicin (from garlic) induces caspase-mediated apoptosis in cancer cells,” European Journal of Pharmacology, vol. 485, no. 1–3, pp. 97–103, 2004. View at Publisher · View at Google Scholar · View at Scopus
120. J. Y. Kim and O. Kwon, “Garlic intake and cancer risk: an analysis using the Food and Drug Administration's evidence-based review system for the scientific evaluation of health claims,” The American Journal of Clinical Nutrition, vol. 89, no. 1, pp. 257–264, 2009. View at Publisher · View at Google Scholar · View at Scopus
121. G. M. Suddek, “Allicin enhances chemotherapeutic response and ameliorates tamoxifen-induced liver injury in experimental animals,” Pharmaceutical Biology, vol. 52, no. 8, pp. 1009–1014, 2014. View at Publisher · View at Google Scholar
122. T. Miron, M. Mironchik, D. Mirelman, M. Wilchek, and A. Rabinkov, “Inhibition of tumor growth by a novel approach: in situ allicin generation using targeted alliinase delivery,” Molecular Cancer Therapeutics, vol. 2, no. 12, pp. 1295–1301, 2003. View at Google Scholar · View at Scopus
123. D. Y. Shin, G.-Y. Kim, H. J. Hwang, W.-J. Kim, and Y. H. Choi, “Diallyl trisulfide-induced apoptosis of bladder cancer cells is caspase-dependent and regulated by PI3K/Akt and JNK pathways,”Environmental Toxicology and Pharmacology, vol. 37, no. 1, pp. 74–83, 2014. View at Publisher · View at Google Scholar · View at Scopus
124. L. Xu, J. Yu, D. Zhai et al., “Role of JNK activation and mitochondrial bax translocation in allicin-induced apoptosis in human ovarian cancer SKOV3 cells,” Evidence-Based Complementary and Alternative Medicine, vol. 2014, Article ID 378684, 6 pages, 2014. View at Publisher · View at Google Scholar
125. G. Sigounas, J. Hooker, A. Anagnostou, and M. Steiner, “S-allylmercaptocysteine inhibits cell proliferation and reduces the viability of erythroleukemia, breast, and prostate cancer cell lines,”Nutrition and Cancer, vol. 27, no. 2, pp. 186–191, 1997. View at Publisher · View at Google Scholar ·View at Scopus
126. H. Amagase and J. A. Milner, “Impact of various sources of garlic and their constituents on 7,12-dimethylbenz[a]anthracene binding to mammary cell DNA,” Carcinogenesis, vol. 14, no. 8, pp. 1627–1631, 1993. View at Publisher · View at Google Scholar · View at Scopus